Deslorelin Acetate

본문 바로가기


Home > Product > Deslorelin Acetate
Product
Deslorelin Acetate
Posting date : Sep 14, 2016
Membership
Free Member Scince Sep 14, 2016
FOB Price
Negotiable
Min. Order Quantity
5 grams
Supply Abillity
200 Kilograms/Month
Port
ShenZhen , ShangHai, HongKong
Payment Terms
Western Union, MoneyGram, T/T
Package
well package
Keyword :
Category
Contact
Alan
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
yuancheng
HS-CODE
2816-10
Package & Delivery Lead Time
Package
well package
Delivery Lead Time
within 3 days after payment
Detailed Description
Product Name    Deslorelin Acetate Sequence     Glp-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEtCas No.     57773-65-5Molecular Formula     C64H83N17O12Molecular Weight     1282.47Purity (HPLC)    99.0%min.Appearance?    White powderSingle Impurity (HPLC)?    0.5%maxAmino Acid Composition?    ±10% of theoreticalPeptide Content (N%)    ≥80.0% Water Content (Karl Fischer)?    ≤8.0%Acetate Content (HPIC)    ≤12.0%MS (ESI)    ConsistentMass Balance?    95.0~105.0%
Description:
Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. It stops the production of sex hormones (testosterone and oestrogen).Deslorelin Acetate is marketed by Peptech with the brand name Ovuplant. It is currently approved for use in veterinary medicine and is used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock. Unlike other GnRH agonists, which are mainly used to inhibit luteinizing hormone and follicle-stimulating hormone by their ultimate downregulation of the pituitary gland, Deslorelin is primarily used for the initial flare effect upon the pituitary, and its associated surge of LH secretion.
Application:
Deslorelin was successfully trialed in the US and was approved for veterinary use under certain circumstances. In Europe, it was approved for use in equine assisted reproduction.It is also being trialed in humans to study its efficacy in treatment of breast cancer in women, and in treating precocious puberty and congenital adrenal hyperplasia in male and female children.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top